Monopar Therapeutics Inc (MNPR)
$70.32 -2.21% Close Oct 30, 2026 Live
Monopar Therapeutics stock today
Monopar Therapeutics closed at $70.32 on October 30, 2026, down 2.21% on the day. Over the past year it returned -17.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $471 million.
$50.00$75.00$100.00$125.00
NovJan 2026MarMayJulSep
| Period | MNPR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -11.7% | -0.9% |
| 3 months | -38.7% | +2.1% |
| Year to date | +7.7% | +11.7% |
| 1 year | -17.9% | +12.4% |
| 3 years | +3,381% | +88.5% |
| 5 years | +193.0% | +76.0% |
Key statistics
- Market value
- $471M
- 52-week range
- $50.12 to $123.84
- Next report
- Nov 12, 2026 (estimated)
About Monopar Therapeutics
Monopar Therapeutics develops immunotherapies for cancer and infectious diseases.
Sector: Health Care
More on Monopar Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $2,930 today
No forecast, no recommendation. This page describes Monopar Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.